Search Results - Arechavaleta-Granell, María del Rosario

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial by le Roux, Carel W, Prof, Astrup, Arne, Prof, Fujioka, Ken, MD, Greenway, Frank, Prof, Lau, David C W, Prof, Van Gaal, Luc, Prof, Ortiz, Rafael Violante, MD, Wilding, John P H, Prof, Skjøth, Trine V, MD, Manning, Linda Shapiro, MD, Pi-Sunyer, Xavier, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Metabolic dysfunction-associated steatotic liver disease and atherosclerosis

    Metabolic dysfunction-associated steatotic liver disease and atherosclerosis by Castillo-Núñez, Yulino, Almeda-Valdes, Paloma, González-Gálvez, Guillermo, Arechavaleta-Granell, María del Rosario

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: